Taylor Ben R
Insider CIK 1712276 · TYME President, CFO · RXRX Chief Financial Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| RXRX RECURSION PHARMACEUTICALS, | F Tax w/h | 2026-09-15 | 2026-09-16 | 5,396 | $3.41 | $18.4K | 1,071,462 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | F Tax w/h | 2026-09-15 | 2026-09-16 | 5,396 | $3.41 | $18.4K | 1,071,462 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | F Tax w/h | 2026-08-17 | 2026-08-18 | 25,018 | $3.16 | $79.1K | 1,076,858 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | F Tax w/h | 2026-08-17 | 2026-08-18 | 25,018 | $3.16 | $79.1K | 1,076,858 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | F Tax w/h | 2026-06-15 | 2026-06-17 | 5,396 | $3.15 | $17.0K | 1,101,876 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | F Tax w/h | 2026-05-15 | 2026-05-19 | 25,018 | $3.04 | $76.1K | 1,107,272 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | F Tax w/h | 2026-04-06 | 2026-04-08 | 48,028 | $3.11 | $149.4K | 1,132,290 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | S Sale | 2026-03-17 | 2026-03-18 | 7,956 | $3.39 | $27.0K | 1,180,318 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | F Tax w/h | 2026-03-16 | 2026-03-18 | 7,075 | $3.42 | $24.2K | 1,188,274 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | S Sale | 2026-02-18 | 2026-02-19 | 13,426 | $3.08 | $41.4K | 1,195,349 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | F Tax w/h | 2026-02-17 | 2026-02-19 | 11,908 | $3.49 | $41.6K | 1,208,775 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | F Tax w/h | 2026-02-06 | 2026-02-10 | 11,400 | $3.98 | $45.4K | 1,220,683 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | A Award | 2026-02-06 | 2026-02-10 | 24,254 | — | $0 | 1,232,083 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | A Award | 2026-02-06 | 2026-02-10 | 446,279 | — | $0 | 1,207,829 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | S Sale | 2025-12-29 | 2025-12-30 | 21,383 | $4.18 | $89.4K | 761,550 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | F Tax w/h | 2025-12-15 | 2025-12-17 | 7,057 | $4.33 | $30.6K | 782,933 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | F Tax w/h | 2025-11-25 | 2025-11-26 | 2,271 | $4.03 | $9.2K | 789,990 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | F Tax w/h | 2025-11-17 | 2025-11-19 | 11,908 | $4.14 | $49.3K | 792,261 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | F Tax w/h | 2025-09-15 | 2025-09-17 | 7,057 | $4.83 | $34.1K | 804,169 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | F Tax w/h | 2025-08-15 | 2025-08-19 | 11,908 | $5.64 | $67.2K | 811,226 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | F Tax w/h | 2025-06-16 | 2025-06-18 | 7,057 | $4.92 | $34.7K | 823,134 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | F Tax w/h | 2025-05-15 | 2025-05-19 | 11,908 | $4.25 | $50.6K | 830,191 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | F Tax w/h | 2025-04-01 | 2025-04-03 | 26,571 | $5.10 | $135.5K | 842,099 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | F Tax w/h | 2025-03-17 | 2025-03-19 | 7,057 | $6.84 | $48.3K | 868,670 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | F Tax w/h | 2025-02-18 | 2025-02-20 | 10,879 | $10.64 | $115.8K | 875,727 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | A Award deriv | 2025-02-03 | 2025-02-05 | 70,037 | — | $0 | 70,037 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | A Award | 2025-02-03 | 2025-02-05 | 35,018 | — | $0 | 879,228 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | A Award | 2025-02-03 | 2025-02-05 | 13,922 | — | $0 | 893,150 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | F Tax w/h | 2025-02-03 | 2025-02-05 | 6,544 | $7.25 | $47.4K | 886,606 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | A Award deriv | 2024-12-19 | 2024-12-20 | 740,686 | — | $0 | 740,686 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | A Award | 2024-12-19 | 2024-12-20 | 370,343 | — | $0 | 844,210 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | F Tax w/h | 2024-12-17 | 2024-12-18 | 7,057 | $6.95 | $49.0K | 473,867 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | F Tax w/h | 2024-12-16 | 2024-12-18 | 15,668 | $6.04 | $94.6K | 480,924 | SEC↗ |
| TYME TYME TECHNOLOGIES, INC. | A Award deriv | 2020-05-07 | 2020-05-18 | 360,000 | — | $0 | 360,000 | SEC↗ |
| TYME TYME TECHNOLOGIES, INC. | P Buy | 2019-06-14 | 2019-06-17 | 10,000 | $1.01 | $10.1K | 10,000 | SEC↗ |
| TYME TYME TECHNOLOGIES, INC. | A Award deriv | 2019-05-03 | 2019-05-07 | 469,300 | — | $0 | 469,300 | SEC↗ |
| TYME TYME TECHNOLOGIES, INC. | A Award deriv | 2018-06-30 | 2020-05-18 | 1,500,000 | — | $0 | 1,500,000 | SEC↗ |
| TYME TYME TECHNOLOGIES, INC. | A Award deriv | 2018-05-24 | 2018-05-29 | 400,000 | — | $0 | 400,000 | SEC↗ |
| TYME TYME TECHNOLOGIES, INC. | A Award deriv | 2017-11-22 | 2017-11-27 | 129,957 | — | $0 | 129,957 | SEC↗ |
| TYME TYME TECHNOLOGIES, INC. | A Award deriv | 2017-11-22 | 2017-11-27 | 50,000 | — | $0 | 50,000 | SEC↗ |